Resmed Inc. buy Needham & Company LLC
Start price
25.01.24
/
50%
€173.80
Target price
25.01.25
€197.59
Performance (%)
36.54%
End price
26.01.25
€237.30
Summary
This prediction ended on 26.01.25 with a price of €237.30. With a performance of 36.54% the BUY prediction by Needham___Company_LL was a big success. Dividends of €1.87 are taken into consideration when calculating the performance. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | -8.269% | -8.269% | -0.148% |
| iShares Core DAX® | -1.338% | -5.619% | 3.378% |
| iShares Nasdaq 100 | -1.067% | 2.598% | 19.132% |
| iShares Nikkei 225® | -1.991% | -6.512% | 27.854% |
| iShares S&P 500 | -1.316% | 0.905% | 14.189% |
Comments by Needham___Company_LL for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Needham & Company LLC from $180.00 to $215.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten